Mechanisms of age-related RPE dysfunction and CNV
年龄相关的 RPE 功能障碍和 CNV 的机制
基本信息
- 批准号:8263308
- 负责人:
- 金额:$ 39.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAge related macular degenerationAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsAutophagocytosisAutophagosomeBiological AssayBlindnessBruch&aposs basal membrane structureCandidate Disease GeneCellsChloroquineChoroidChoroidal NeovascularizationChronicClinical TreatmentCoculture TechniquesComplementDataDepositionDevelopmentDietDiseaseDisease ProgressionDrug Metabolic DetoxicationDrusenElderlyEtiologyExperimental ModelsExudative age-related macular degenerationEyeFatty acid glycerol estersFunctional disorderGene Expression ProfileGenesGeneticGenetic ResearchHumanImmune responseInfiltrationInflammationInflammatoryInflammatory ResponseInterventionKnock-outKnockout MiceKnowledgeLeadLesionLeucineLightLipofuscinLysosomesMacrophage ActivationMapsMeasuresMediatingMembraneMetabolicMicrotubule-Associated ProteinsModelingMolecularMolecular TargetMusMyeloid CellsPathologic ProcessesPathologyPathway interactionsPeroxisome Proliferator-Activated ReceptorsPhagocytosisPhotoreceptorsProductionProgressive DiseasePropertyProtein Export PathwayProteinsProteolysisProteomicsReporterRetinaRetinalRoleStagingStimulusStructure of retinal pigment epitheliumSystemTestingTissue-Specific Gene ExpressionToxic effectVacuoleVesicleWild Type MouseWorkage relatedbasecell typechemokinecomplement systemcytokinedesigngene functiongeographic atrophyin vivoinhibition of autophagyinhibitor/antagonistmacromoleculemacrophagemouse modelnovelnovel therapeuticsnuclear factor-erythroid 2overexpressionrepairedresearch studyresponsesmall hairpin RNAsubretinal injectiontool
项目摘要
DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of blindness in elderly people. The disease starts with dysfunction of the retinal pigment epithelium (RPE) and formation of drusen, and will further progress to chronic inflammation in the sub-RPE space, geographic atrophy and choroidal neovascularization (CNV). Despite the recent progresses in genetic research and clinical treatment of exudative AMD, its etiology is largely unclear and currently there is no effective cure for dry AMD. We have recently developed an animal model of AMD using knockout mice deficient of nuclear factor erythroid 2-related factor 2 (Nrf2). The Nrf2-/- mice developed AMD-like retinal pathology including age-dependent RPE degeneration, spontaneous CNV and sub-RPE deposit of complement-related proteins. In our preliminary studies, we further demonstrated that Nrf2 is an important regulator of RPE autophagy and macrophage activation. We found that Nrf2-deficient RPE cells had increased accumulation of autophagic vacuoles and lipofuscin in vivo, indicating less efficient degradation by lysosome. Substantially more severe RPE pathology was developed in Nrf2-/- mice in a chronic toxicity model using chloroquine, an inhibitor of lysosome function and RPE autophagy. With differential gene expression assay, we identified Nramp1 as a downstream gene of Nrf2 with novel functions of controlling autophagosome formation. In a model of experimental CNV, Nrf2-/- mice showed significantly increased lesion size and macrophage infiltration than the wild type mice received the same treatment. When co-cultured with RPE, Nrf2-/- macrophages showed more robust pro-inflammatory responses than the wild type cells. Based on these findings, we hypothesize that Nrf2 is an essential regulator of multiple protective mechanisms against age-dependent RPE dysfunction and subsequent CNV. Using Nrf2-/- mice as an established model, experiments will be performed to further examine the mechanisms of RPE degeneration and to explore the roles of chronic inflammation mediated by infiltrating macrophages. Specific Aim 1 will determine whether Nrf2 regulates RPE autophagy by Nramp1-dependent mechanisms. Specific Aim 2 will determine whether inhibiting RPE autophagy will accelerate the development of AMD-related pathology in Nrf2-/- mice, and examine the functional interactions between RPE autophagy pathway and exosomal protein export. Specific Aim 3 will determine whether Nrf2 regulates polarized macrophage activation in experimental CNV. Results from these studies will reveal new mechanisms of the pathobiology of AMD and further define Nrf2 as a molecular target for intervention.
PUBLIC HEALTH RELEVANCE: This project will use a newly developed mouse model of age-related macular degeneration (AMD) to examine the essential roles of nuclear factor erythroid 2-related factor 2 (Nrf2) in protecting the outer retina from age-related degeneration and associated immune responses. Results from the proposed studies can expand our knowledge on the molecular etiology of AMD and facilitate the design of better interventional agents that protect against vision loss in elderly people.
描述(由申请人提供):与年龄相关的黄斑变性(AMD)是老年人失明的主要原因。该疾病始于视网膜色素上皮(RPE)的功能障碍和DRUSEN的形成,并将进一步发展为子RPE空间,地理萎缩和脉络膜新生血管形成(CNV)的慢性炎症。尽管最近在渗出症AMD的遗传研究和临床治疗方面取得了进展,但其病因在很大程度上尚不清楚,目前尚无有效的干疗法。我们最近使用缺乏与核因子2相关因子2(NRF2)的敲除小鼠开发了AMD的动物模型。 NRF2 - / - 小鼠开发了AMD样性视网膜病理学,包括年龄依赖性的RPE变性,自发CNV和补体相关蛋白的子RPE沉积。在我们的初步研究中,我们进一步证明了NRF2是RPE自噬和巨噬细胞激活的重要调节剂。我们发现NRF2缺陷型RPE细胞在体内积聚了自噬液泡和脂肪霉素的积累,表明溶酶体的效率降解较低。使用溶酶体功能和RPE自噬的抑制剂氯喹,在慢性毒性模型中,在NRF2 - / - 小鼠中开发了更严重的RPE病理。使用差异基因表达测定,我们将NRAMP1鉴定为NRF2的下游基因,具有控制自噬体形成的新功能。在实验CNV的模型中,NRF2 - / - 小鼠的病变大小和巨噬细胞浸润明显增加,而野生型小鼠则接受了相同的治疗方法。与RPE共培养时,NRF2 - / - 巨噬细胞显示出比野生型细胞更强大的促炎反应。基于这些发现,我们假设NRF2是针对年龄依赖性RPE功能障碍和随后的CNV的多种保护机制的重要调节剂。将使用NRF2 - / - 小鼠作为既定模型,将进行实验,以进一步检查RPE变性的机制,并探索渗透巨噬细胞介导的慢性炎症的作用。具体目标1将确定NRF2是否通过NRAMP1依赖性机制调节RPE自噬。具体目标2将确定抑制RPE自噬是否会加速NRF2 - / - 小鼠中与AMD相关病理的发展,并检查RPE自噬途径与外泌体蛋白质导出之间的功能相互作用。具体目标3将确定NRF2是否调节实验CNV中的极化巨噬细胞激活。这些研究的结果将揭示AMD病理生物学的新机制,并进一步将NRF2定义为干预的分子靶标。
公共卫生相关性:该项目将使用与年龄相关的黄斑变性(AMD)新开发的小鼠模型,以检查核因子红细胞2相关因子2(NRF2)在保护外部视网膜免受年龄相关变性和相关免疫反应中的基本作用。拟议的研究的结果可以扩大我们对AMD分子病因的了解,并促进更好的介入药物的设计,以防止老年人的视力丧失。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIYANG CAI其他文献
JIYANG CAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIYANG CAI', 18)}}的其他基金
Metabolic reprogramming of endothelial precursor cells in subretinal fibrosis
视网膜下纤维化中内皮前体细胞的代谢重编程
- 批准号:
10752924 - 财政年份:2023
- 资助金额:
$ 39.61万 - 项目类别:
Choroidal Gamma Delta T Cells as Novel Regulators of RPE Degeneration
脉络膜 Gamma Delta T 细胞作为 RPE 变性的新型调节剂
- 批准号:
10133081 - 财政年份:2018
- 资助金额:
$ 39.61万 - 项目类别:
Choroidal Gamma Delta T Cells as Novel Regulators of RPE Degeneration
脉络膜 Gamma Delta T 细胞作为 RPE 变性的新型调节剂
- 批准号:
10005361 - 财政年份:2018
- 资助金额:
$ 39.61万 - 项目类别:
Mechanisms of age-related RPE dysfunction and CNV
年龄相关的 RPE 功能障碍和 CNV 的机制
- 批准号:
9145914 - 财政年份:2012
- 资助金额:
$ 39.61万 - 项目类别:
Mechanisms of age-related RPE dysfunction and CNV
年龄相关的 RPE 功能障碍和 CNV 的机制
- 批准号:
8481553 - 财政年份:2012
- 资助金额:
$ 39.61万 - 项目类别:
Mechanisms of age-related RPE dysfunction and CNV
年龄相关的 RPE 功能障碍和 CNV 的机制
- 批准号:
9087253 - 财政年份:2012
- 资助金额:
$ 39.61万 - 项目类别:
Mechanisms of age-related RPE dysfunction and CNV
年龄相关的 RPE 功能障碍和 CNV 的机制
- 批准号:
8689044 - 财政年份:2012
- 资助金额:
$ 39.61万 - 项目类别:
Mitochondrial DNA Variations and Susceptibility to Oxidative Injury in the RPE
RPE 中线粒体 DNA 变异和氧化损伤的易感性
- 批准号:
7530551 - 财政年份:2008
- 资助金额:
$ 39.61万 - 项目类别:
Mitochondrial DNA Variations and Susceptibility to Oxidative Injury in the RPE
RPE 中线粒体 DNA 变异和氧化损伤的易感性
- 批准号:
7667245 - 财政年份:2008
- 资助金额:
$ 39.61万 - 项目类别:
Mitochondrial Oxidative Stress and Protection in Pesticide-induced Neurotoxicity
农药引起的神经毒性中的线粒体氧化应激和保护
- 批准号:
7516477 - 财政年份:2006
- 资助金额:
$ 39.61万 - 项目类别:
相似国自然基金
基于“肝—眼轴”的枸杞子及其复方防治青少年近视与年龄相关性黄斑变性的功效物质与生物学机制研究
- 批准号:U21A20408
- 批准年份:2021
- 资助金额:260.00 万元
- 项目类别:
基于“肝-眼轴”的枸杞子及其复方防治青少年近视与年龄相关性黄斑变性的功效物质与生物学机制研究
- 批准号:
- 批准年份:2021
- 资助金额:260 万元
- 项目类别:
PGF突变介导的周细胞与内皮细胞crosstalk在湿性年龄相关性黄斑变性中的作用及机制研究
- 批准号:82000898
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
组织病理结构与临床检查对照观察在指导渗出性年龄相关性黄斑变性诊治中的意义研究
- 批准号:81400409
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
基于多模态医学影像技术的湿性年龄相关性黄斑变性诊断与分析
- 批准号:81371629
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
相似海外基金
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
- 批准号:
10726508 - 财政年份:2023
- 资助金额:
$ 39.61万 - 项目类别:
Deciphering the role of mitochondrial/autophagy dysfunction in regulating inflammatory processes during AMD pathogenesis
破译线粒体/自噬功能障碍在 AMD 发病机制中调节炎症过程中的作用
- 批准号:
10664118 - 财政年份:2023
- 资助金额:
$ 39.61万 - 项目类别:
Epigenetic Modifiers to treat Photoreceptor Degenerations
表观遗传修饰剂治疗光感受器变性
- 批准号:
10693776 - 财政年份:2023
- 资助金额:
$ 39.61万 - 项目类别:
Ocular surface applications of Descemet's membrane
后弹力层在眼表的应用
- 批准号:
10448019 - 财政年份:2022
- 资助金额:
$ 39.61万 - 项目类别: